Issue Date | Title | Author(s) |
2024 | Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yin, Hewen; Suo, Shanshan; Yu, Wenjuan; Jin, Jie |
2019 | Emission inventory of semi-volatile and intermediate-volatility organic compounds and their effects on secondary organic aerosol over the Pearl River Delta region | Wu, Liqing; Wang, Xuemei; Lu, Sihua; Shao, Min; Ling, Zhenhao |
18-Dec-2024 | Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study | Zhang, Yi; Zhou, Hu; Suo, Shanshan; Zhuang, Junling; Yang, Linhua; He, Aili; Liu, Qingchi; Du, Xin; Gao, Sujun; Li, Yarong; Li, Yan; Chen, Yuqing; Wu, Wen; Zhu, Huanling; He, Guangsheng; Hong, Mei; Jiang, Qian; Jiang, Zhongxing; Jing, Hongmei; Wang, Jishi; Xu, Na; Yue, Lingling; Zheng, Cuiping; Zhou, Zeping; Jin, Chenghao; Li, Xin; Liu, Lin; Xu, Yajing; Wu, Dengshu; Zhang, Feng; Zhang, Jin; Wu, Liqing; Yin, Hewen; Lv, Binhua; Xiao, Zhijian; Jin, Jie |
20-Mar-2021 | A gridded emission inventory of semi-volatile and intermediate volatility organic compounds in China | Wu, Liqing; Ling, Zhenhao; Liu, Huan; Shao, Min; Lu, Sihua; Wu, Luolin; Wang, Xuemei |
18-Oct-2023 | Precise Control of Trypsin Immobilization by a Programmable DNA Tetrahedron Designed for Ultrafast Proteome Digestion and Accurate Protein Quantification | Fan, Xiaoxue; Chu, Zhanying; Zhu, Manman; Song, Yumeng; Zhao, Yang; Meng, Bo; Gong, Xiaoyun; Zhang, Di; Jiang, You; Wu, Liqing; Tamiya, Keiichi; Yu, Xiaoping; Zhai, Rui; Dai, Xinhua; Fang, Xiang |
20-Apr-2021 | Roles of Semivolatile/Intermediate-Volatility Organic Compounds on SOA Formation Over China During a Pollution Episode: Sensitivity Analysis and Implications for Future Studies | Wu, Liqing; Ling, Zhenhao; Shao, Min; Liu, Huan; Lu, Sihua; Zhou, Shengzhen; Guo, Junchen; Mao, Jingying; Hang, Jian; Wang, Xuemei |
Oct-2022 | Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial | Zhang, Yi; Zhou, Hu; Jiang, Zhongxing; Wu, Dengshu; Zhuang, Junling; Li, Wei; Jiang, Qian; Wang, Xiuli; Huang, Jinwen; Zhu, Huanling; Yang, Linhua; Du, Xin; Li, Fei; Xia, Ruixiang; Zhang, Feng; Hu, Jianda; Li, Yan; Hu, Yu; Liu, Jing; Jin, Chenghao; Sun, Kai; Zhou, Zeping; Wu, Liqing; Yu, Wenjuan; Jin, Jie |